Selection of blockbuster announcements

1、$Byd Company Limited (01211.HK) $It is proposed to increase the capital of the automobile industry by 1.7 billion US dollars.

Byd Company Limited announcement, based on the needs of production, operation and business development of BYD Automotive Industry Co., Ltd. (hereinafter referred to as "Automotive Industry"), a wholly-owned subsidiary of Byd Company Limited Co., Ltd., on November 19, 2021, the 16th meeting of the Seventh Board of Directors of the company examined and adopted the "proposal to increase Capital to wholly-owned subsidiaries", agreeing that the company should increase its capital to wholly-owned subsidiaries by US $1.7 billion or the equivalent RMB in monetary terms. And authorize the management of the company to handle the matters related to the above capital increase. The company intends to increase the capital of the automobile industry by US $1.7 billion or the equivalent RMB in the form of currency, and the above amount of capital increase will be fully included in the registered capital of the automobile industry.

2、$China Evergrande New Energy Vehicle (00708.HK) $The proposed placing shares will raise about HK $2.7 billion for the smooth commissioning of new energy vehicles

China Evergrande New Energy Vehicle announced on the Hong Kong Stock Exchange that the company signed a placing and subscription agreement with the placing agent on November 19, 2021 to place 900 million shares at HK $300 per share through the old-to-new approach. the total expected proceeds from the placing is about HK $2.7 billion (the net proceeds are about HK $2.646 billion). The company intends to use the income collected specifically for the R & D and manufacturing of the group's new energy vehicles, so as to lay the foundation for the smooth commissioning of Hengchi new energy vehicles. The allotment shares account for about 9.05% of the total issued shares at the date of the announcement and about 8.30% of the total issued shares after the completion of the subscription.

3、$Bilibili Inc.-SW (09626.HK) $The sale of US $1.4 billion convertible preferred notes, with a conversion premium of about 40%, will resume trading today.

Bilibili Inc.-SW announces that the Convertible preferred Notes due in 2026 with a total principal amount of US $1.4 billion have been priced and sold to buyers of qualified institutions in accordance with the exemption from registration provisions under Section 144A of the US Securities Act (revised) of 1933. In addition, the company has granted 30-day options to the initial buyer of the note sale to purchase an additional note with a principal amount of up to $200 million. The initial conversion rate of the note is the conversion rate of 10.6419 American depositary shares of the company for every $1000 of principal (equivalent to the initial conversion price of approximately $93.97 per American depositary share, and the conversion premium of more than 40 per cent of the company's American depositary shares at the closing price of $67.12 per American depositary share on November 18, 2021). The company intends to use the net proceeds from the sale of bills for rich content, research and development and general corporate purposes. In addition, the company has applied to the Hong Kong Stock Exchange for the resumption of trading in Class Z common shares on the Hong Kong Stock Exchange from 09:00 on 22 November 2021.

4、$Semiconductor Manufacturing International Corporation (00981.HK) $A total of 4.3943 million share purchase options were granted on November 19th

Semiconductor Manufacturing International Corporation announced that on November 19, 2021, a total of 4.3943 million share option options for the ordinary shares of the company listed on the Stock Exchange were conditionally granted under the 2014 share option Scheme adopted by the Company and effective on November 15, 2013. The exercise price of the share option is HK $22.41 per Hong Kong share, a premium of 0.95% over the closing price of HK $22.20 on November 19th. The share option is valid for 10 years from November 19, 2021.

5、$CITIC Limited (00267.HK) $It is proposed to spin off CITIC Metal shares and list them independently on the Shanghai Stock Exchange.

CITIC Limited announced that the company proposes to independently list the shares of CITIC Metal Co., Ltd. (CITIC Metal Co., Ltd.), an indirect wholly-owned subsidiary established in China, on the Shanghai Stock Exchange. Citic Metal is expected to submit its listing application to the China Securities Regulatory Commission by the end of 2021. Citic Metal Co., Ltd. is mainly engaged in mineral trading (including iron ore, steel, niobium, other non-ferrous metals and other products). Citic Metal's main investments include CompanhiaBrasileira de Metalurgia e Minera ã o, Minera Las Bambas S.A. And the equity investment of Ivanhoe Mines Limited companies.

6、$Hansoh Pharmaceutical Group (03692.HK) $The antineoplastic drug "flurovir group injection" was registered and approved.

Hansoh Pharmaceutical Group announced that the "Fluvex Group injection" developed by Jiangsu Hausen Pharmaceutical Co., Ltd. has been approved by the State Drug Administration of China. The product is an antineoplastic drug and is used in the treatment of locally advanced postmenopausal estrogen receptor positive or metastatic breast cancer after or during antiestrogen adjuvant therapy or in the course of antiestrogen therapy.

• Financial report data

Huishang Bank (03698): net profit for the first nine months increased by 19.2% year-on-year to 9.461 billion yuan

Oriental Enterprise Control Group (00018): medium-term profit attributable to shareholders decreased by 19.25% year-on-year to HK $70.515 million

Bandung Holdings Group (00030): expected loss attributable to shareholders in the medium term is not less than HK $83 million

Oceanwide Group (00129): expected medium-term profit to be significantly reduced by about 75 to 80 per cent

Oceanwide Hotel (00292): expected medium-term net loss of about HK $150 million

• H-share interaction

CITIC Limited (00267): plans to spin off CITIC Metal shares and list independently on the Shanghai Stock Exchange

• Resume trading and suspend trading

Bilibili Inc.-SW (09626): issue US $1.4 billion convertible preferred notes at a conversion premium of about 40%, and resume trading today

• Important matters

Cornerstone Pharmaceutical-B (02616): strategic Cooperation with Hengrui Pharmaceutical on CS1002 in Greater China

Junshi Bio (01877): clinical trial application for prevention and treatment of COVID-19 drug JS026 injection was approved

Deqi Medicine-B (06996): Cerineso Phase I/II Clinical study approved

Centro Healthcare-B (06669): establishing an American R & D Center

Keji Pharmaceutical-B (02171): CT041's application for clinical trials is approved by Health Canada

CSPC Pharmaceutical (01093): entered into an exclusive license agreement with Chengdu Conoya for CM326

Fudan Zhangjiang (01349): application for clinical trials of JAK1 selective inhibitors for ulcerative colitis

Hansoh Pharmaceutical Group (03692): the antineoplastic drug "flurosemide injection" was approved for drug registration.

Byd Company Limited (01211): plans to increase the capital of the automobile industry by 1.7 billion US dollars to the wholly owned subsidiary.

Bank of China Leasing (01606): signed a 650 million yuan financial lease contract with Anyang Yongge

Zhengshang Industry (00185): affiliated acquisition of land use rights of a plot in Zhengzhou, Henan Province with 421 million yuan

China Everbright Water (01857): conclude cooperation agreement and PPP project contract, the total investment of the project is estimated to be 208 million yuan

China Biotechnology Service (08037): the project of BNCT (Boron Neutron) Cancer treatment Center has been admitted to Hainan Boao International Medical Tourism advance area in principle.

• Bond bill

China Rallway (00390): plans to issue corporate bonds of no more than 3 billion yuan

New Oriental Education & Technology Group-S (09901): buy back $300 million of bonds maturing in 2025 with a total principal of $75.5 million

• Merger and acquisition and sale

Cosco Group (03377): the subsidiary intends to acquire a 30% stake in Cosco Logistics Real Estate for 780 million yuan.

New higher Education Group (02001): plans to acquire the remaining shares of Harbin Huade Institute for 292.5 million yuan

Zhengshang Industry (00185): successfully bid for Zhengzhou Land in Henan Province with 421 million yuan

Original ecological animal husbandry (01431): plans to acquire assets such as Shaanxi dairy goat breeding facilities with 131 million yuan.

Jiuyuan Group (00827): plans to acquire 90% stake in Jiangsu Blue Planet Environmental Protection New Materials with 27 million yuan to expand chemical business and enhance core competitiveness

• Change of equity

New Oriental Education & Technology Group online (01797): chairman Yu Minhong increased his holdings of 1.429 million shares

AAC Technologies Holdings Inc. (02018): 500000 shares increased by Pan Zhengmin, Executive Director and Chief Executive Officer

Nuohui Health-B (06606): shareholder Mai Shaoxian increased his stake in 3.173 million shares

• Additional placement

China Evergrande New Energy Vehicle (00708): plan to place 900 million shares from old to new to raise HK $2.7 billion each at HK $3

Liao Hong Kong shares (02880): issue about 1.364 billion shares to 8 investors to raise no more than 2.1 billion yuan

Semiconductor Manufacturing International Corporation (00981): granted a total of 4.3943 million share purchase options on November 19th

• Repurchase cancellation

HSBC Holdings PLC (00005): 15.4338 million pounds to buy back 3.509 million shares on November 18th